Peptides, FDA Approval & Longevity Trends: Dr. Myles Spar Separates Science From Hype
Автор: The LIVING Room Podcast | Inside The WNDR Lab
Загружено: 2026-07-17
Просмотров: 1991
Описание:
The peptide space is exploding. Claims are everywhere. But for most peptides, the human evidence is still surprisingly limited.
Dr. Myles Spar is a board-certified Internal Medicine physician, Integrative Medicine physician, and Clinical Translator at The WNDR Lab. He has spent his career helping translate longevity science into practical medicine, and in this conversation, he breaks down one of the most talked-about topics in health today: peptide therapy.
From BPC-157 and TB-500 to MOTS-c and GHK Copper, Dr. Spar explains why the excitement has outpaced the evidence, what the FDA's proposed recategorization of certain peptides actually means (and what it doesn't), and how to evaluate health claims before putting anything in your body.
The conversation also explores how to separate evidence from hype, why correlation isn't causation, and why the fundamentals of health still outperform any shortcut.
This episode also marks the launch of a new recurring series "“The Truth Behind the Trend” on The LIVING Room Podcast. In this series, Chris Wharton sits down with leading experts in their fields to examine what's making the news, what the science actually says, and what it means for your health. These shorter conversations are designed to help you think more critically, ask better questions, and separate evidence from hype.
What we cover in this episode:
Why most peptide research is still limited—and why that matters
BPC-157, TB-500, MOTS-c, and GHK Copper: what we know today
What the FDA's proposed peptide recategorization means—and why it does not mean FDA approval
The difference between FDA-approved, FDA-cleared, and compounded products
Why injectable peptides have more evidence behind them than patches, creams, and sublingual formulations
The risks of buying peptides from unregulated sources
Why therapeutic plasma exchange may be overhyped in longevity medicine
The "proof commensurate with harm" principle for evaluating health interventions
Why correlation does not equal causation in health research
How to run your own N-of-1 experiment to determine what actually works for you
Why exercise, sleep, nutrition, stress management, and other fundamentals remain the foundation of longevity
If you're trying to make sense of the rapidly growing world of peptides, biohacking, and longevity medicine, this episode offers a practical, evidence-based framework for thinking critically about the latest health trends.
Want more? Each month, we send a newsletter curated by our scientific council on what's
actually advancing the science of human longevity — and what isn't.
Subscribe at https://www.thewndrlab.com/mailing-list.
TimeStamps
00:00 Why Is Longevity Medicine Full of Conflicting Claims?
03:07 Who Should You Trust in Longevity Medicine
07:29 Does Peptide Therapy Actually Work?
08:48 What Are Peptides and How Do They Work?
12:05 Are BPC 157 and TB 500 Proven?
13:43 Why Is the FDA Reconsidering Peptide Access?
22:11 How Can You Reduce Peptide Injection Risks?
24:25 Do We Know the Right Peptide Dosage?
29:10 Peptides Cannot Replace Exercise, Sleep, and Nutrition
31:18 What Does FDA-Cleared Actually Mean?
32:33 Is Plasma Exchange Worth the Risk?
#peptidetherapy #LongevityMedicine #BPC157 #TB500 #PeptideSafety
Connect with Dr. Myles Spar:
Instagram: / drspar
LinkedIn: / drspar
Connect with our host Chris Wharton on Instagram: / chriswharton1
Follow The LIVING Room Podcast on Socials:
Instagram: / the.living.room.pod
LinkedIn: linkedin.com/company/wndrlab/
The WNDR Lab: https://www.thewndrlab.com/
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: